Erxi Wu Selected Research

Ovarian Neoplasms (Ovarian Cancer)

12/2015	PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
1/2013	An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erxi Wu Research Topics

Disease

48	Neoplasms (Cancer) 11/2023 - 06/2006
31	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 01/2011
8	Neoplasm Metastasis (Metastasis) 11/2023 - 11/2011
8	Hyperglycemia 10/2015 - 11/2008
6	Inflammation (Inflammations) 01/2022 - 10/2009
5	Infections 06/2022 - 11/2013
5	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 11/2007
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2015
4	Lung Neoplasms (Lung Cancer) 01/2023 - 09/2014
4	Dementia (Dementias) 01/2023 - 09/2017
4	Carcinogenesis 01/2014 - 01/2010
3	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 11/2018
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 01/2020
3	Pain (Aches) 01/2020 - 03/2013
3	Medulloblastoma 02/2015 - 01/2011
2	Parkinson Disease (Parkinson's Disease) 02/2024 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 09/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2023 - 01/2023
2	Disease Progression 01/2023 - 01/2020
2	Multiple System Atrophy 06/2020 - 05/2015
2	Synucleinopathies 01/2020 - 05/2015
2	Neuroblastoma 01/2019 - 05/2009
2	Ischemia 01/2018 - 01/2018
2	Sepsis (Septicemia) 11/2016 - 08/2014
2	Prostatic Neoplasms (Prostate Cancer) 06/2016 - 01/2013
2	Ovarian Neoplasms (Ovarian Cancer) 12/2015 - 01/2013
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2015 - 01/2015
2	Hypoxia (Hypoxemia) 05/2014 - 06/2013
2	Breast Neoplasms (Breast Cancer) 10/2009 - 04/2009
1	Carcinoma (Carcinomatosis) 09/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Fibrosarcoma 06/2022
1	COVID-19 06/2022
1	Chronic Pancreatitis 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 01/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2009
9	CytokinesIBA 01/2021 - 01/2013
8	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2012
6	Gemcitabine FDA Link 04/2022 - 08/2011
6	ResveratrolIBA 01/2020 - 01/2013
6	Small Interfering RNA (siRNA)IBA 12/2015 - 09/2012
6	Glucose (Dextrose)FDA LinkGeneric 10/2015 - 01/2011
5	salinomycinIBA 01/2022 - 01/2013
4	SynucleinsIBA 01/2021 - 05/2015
4	Nerve Growth Factor (NGF)IBA 01/2020 - 02/2011
3	Superoxide DismutaseIBA 01/2018 - 05/2015
3	EnzymesIBA 08/2015 - 10/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2014 - 04/2009
3	Messenger RNA (mRNA)IBA 01/2014 - 04/2009
3	LigandsIBA 06/2013 - 01/2012
3	Matrix Metalloproteinases (MMPs)IBA 03/2013 - 10/2009
2	Metformin (Glucophage)FDA LinkGeneric 02/2024 - 01/2017
2	RNA (Ribonucleic Acid)IBA 09/2023 - 12/2018
2	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2015
2	theanineIBA 06/2022 - 09/2014
2	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 01/2022 - 04/2016
2	Caspase 3 (Caspase-3)IBA 11/2020 - 01/2013
2	Substance PIBA 01/2020 - 03/2013
2	Fluorouracil (Carac)FDA LinkGeneric 11/2018 - 01/2014
2	Free RadicalsIBA 01/2018 - 01/2014
2	AMP-Activated Protein KinasesIBA 01/2017 - 08/2015
2	p38 Mitogen-Activated Protein KinasesIBA 10/2015 - 01/2014
2	DNA-Binding Proteins (DNA Binding Protein)IBA 09/2015 - 01/2015
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2015 - 01/2011
2	mangostinIBA 05/2014 - 01/2014
2	matrigelIBA 01/2014 - 03/2013
2	Blood Glucose (Blood Sugar)IBA 01/2014 - 01/2011
2	cyclopamineIBA 06/2013 - 09/2012
2	Therapeutic UsesIBA 01/2013 - 04/2009
2	Cadherins (E-Cadherin)IBA 01/2013 - 01/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 10/2009
2	Epidermal Growth Factor (EGF)IBA 01/2011 - 04/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2010 - 03/2007
2	TOR Serine-Threonine KinasesIBA 01/2010 - 03/2007
2	NF-kappa B (NF-kB)IBA 10/2009 - 04/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2024
1	Angiotensin Receptor AntagonistsIBA 02/2024
1	ProteomeIBA 11/2023
1	Molecular Probes (Molecular Probe)IBA 09/2023
1	DNA (Deoxyribonucleic Acid)IBA 09/2023
1	ClathrinIBA 09/2023
1	OligonucleotidesIBA 09/2023
1	MethyltransferasesIBA 07/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	3' Untranslated Regions (3' UTR)IBA 01/2023
1	polyphyllin VIIIBA 01/2023
1	5' Untranslated Regions (5' UTR)IBA 01/2023
1	ethyl 6-bromocoumarin-3-carboxylyl theanineIBA 06/2022
1	TeaIBA 06/2022
1	Nucleotide AptamersIBA 06/2022
1	phytobacteriomycin (PBM)IBA 01/2022
1	PTEN-induced putative kinaseIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	lipopolysaccharide-binding proteinIBA 01/2022

Therapy/Procedure

29	Therapeutics 09/2023 - 11/2007
9	Drug Therapy (Chemotherapy) 04/2022 - 06/2006
2	Precision Medicine 01/2023 - 01/2023
2	Immunotherapy 01/2022 - 11/2020
2	Punctures 01/2021 - 11/2016
2	Ligation 01/2021 - 11/2016